Fig. 1From: Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children studyChange in height standard deviation scores (HSDS) in (a) the total efficacy analysis set and (b) pre-treated and naïve patients over 5 years. BL, baselineBack to article page